Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,688,000
-$372,000 QoQ
Shares Held
1,200,000
0.0% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#7
of 54 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GREAT POINT PARTNERS LLC holds $375,251,240 across 36 Biotechnology names. EPRX ranks #18 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
374,000 | $31,479,580 | |
| 2 | VOR |
Vor Biopharma Inc.
|
1,750,000 | $31,220,000 | |
| 3 | ZURA |
Zura Bio Ltd
|
4,215,930 | $25,084,783 | |
| 4 | NKTR |
Nektar Therapeutics
|
316,453 | $22,768,793 | |
| 5 | SLGL |
Sol-Gel Technologies Ltd.
|
274,363 | $21,735,036 | |
| 6 | ALMS |
Alumis Inc.
|
856,061 | $18,859,023 | |
| 7 | DRUG |
Bright Minds Biosciences Inc.
|
220,000 | $16,053,400 | |
| 8 | ANNX |
Annexon, Inc.
|
2,500,000 | $13,850,000 |
All Filings in EPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,688,000 | 1,200,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,060,000 | 1,200,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,080,000 | 1,200,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||